Google Inc. (NASDAQ:GOOG): Square is quickly becoming eBay’s (NASDAQ:EBAY) PayPal and Google’s Wallet offerings’ newest competition. The new company raised $200 million in a recent round of funding giving the company a value of $3.25 billion, reports Financial Times, citing sources. This financing round was headed by investors like Citigroup’s (NYSE:C) Citi Ventures arm and Starbucks (NASDAQ:SBUX). The shares closed at $718.28, up $8.3 or 1.17% on the day. They have traded in a 52-week range of $480.60 to $713.00.
Jazz Pharmaceuticals (NASDAQ:JAZZ) revealed that yesterday it received a claim construction order and opinion, or a “Markman ruling,” from the United States District Court for the District of New Jersey in regards to its continued patent litigation with Roxane Laboratories. The litigation is related to Roxane’s abbreviated new drug application that was filed with the FDA requesting to be approved to sell its generic version of Xyrem oral solution. The company thinks that the Markman ruling is positive to the company’s positions in future litigation. A Markman ruling is an interim order by a court determining the definition of terms included in certain patent claims if one or more of the parties to a lawsuit request it, this can include the court’s decision that some terms do not need construction. The ruling will follow a Markman hearing which is scheduled for April 26. Neither the Markman hearing nor the ruling is to address the new patent concerning Xyrem given to Jazz on September 11, called the “Microbiologically Sound and Stable Solutions of Gamma-Hydroxybutyrate Salt for the Treatment of Narcolepsy.” Jazz expectations point to the next phase of the continued litigation being expert discovery, but as of now, there is no trial date. The shares closed at $57.05, up $1.76 or 3.18% on the day. They have traded in a 52-week range of $34.02 to $56.25.
Schiff Nutrition Int (SHF) sees its FY13 net sales growth at 43 to 46 percent compared to FY12 and compared to the previous outlook of 40 to 43 percent. The company also sees its Fy13 operating margin at 14.5 to 16 percent compared to the previous outlook of 12.5 to 14 percent. The shares closed at $24.37, up $3.47 or 16.6% on the day. They have traded in a 52-week range of $9.21 to $20.92.
Ziprealty (NASDAQ:ZIPR) has entered into a strategic marketing agreement with Citi (NYSE:C) under which Citi is to deliver a multi-level mortgage services platform to Ziprealty that will allowing possible homebuyers using the ZipRealty website to have seamless access to the services necessary from pre-qualification and application tools to dedicated customer service representatives to help with home financing. The shares closed at $2.73, up $0.01 or 0.37% on the day. They have traded in a 52-week range of $1.01 to $2.73.
Are these stocks a buy or sell? Let us help you decide. Check out our Wall St. Cheat Sheet Stock Picker Newsletter now >>